Lead

Johnson & Johnson (J&J) has agreed to pay up to $5.5 billion to resolve tens of thousands of US lawsuits alleging that its talc-based baby powder and other talc products caused ovarian cancer. The proposed settlement, announced on Monday, aims to close a long-running legal battle that has weighed on the healthcare giant for over a decade.

Coverage comparison

The settlement figure and its scope were reported consistently across multiple outlets. ABC Australia reported that J&J will pay an estimated $5.5 billion to resolve about 76,000 claims, including those consolidated in federal court in New Jersey and related state court cases. Al Jazeera and The Hindu both cited the figure of about 69,000 cases, with The Hindu adding that this represents 99.75% of the remaining talc claims. BBC World described the offer as "up to $5.5bn" and noted that the proposal must be accepted by legal firms representing 95% of the ovarian cancer claims in state and federal courts before it can be finalised.

J&J's denial of the allegations was a common thread. Erik Haas, J&J's vice president of litigation, was quoted by ABC Australia and BBC World as calling the claims "meritless," while Al Jazeera reported that J&J maintains there is no evidence that talc causes cancer. The company stopped selling talc-based baby powder in the US in 2020, as noted by ABC Australia and The Hindu, and worldwide in 2023, according to Al Jazeera.

A point of divergence emerged over the number of claims covered. ABC Australia reported 76,000 claims, while Al Jazeera and The Hindu both cited 69,000 cases. The discrepancy may reflect different counting methods or timing, but the core settlement amount remained consistent across all sources.

Key claims

  • J&J will pay an estimated $5.5 billion to resolve lawsuits alleging its talc products caused ovarian cancer, as reported by ABC Australia, Al Jazeera, BBC World, and The Hindu.
  • The settlement covers about 69,000 cases consolidated in federal court and related state court cases, totalling 99.75% of the remaining talc claims, according to Al Jazeera and The Hindu. ABC Australia reported a higher figure of 76,000 claims.
  • J&J has denied that its talc products caused cancer, saying talc was safe and did not contain asbestos, as reported by ABC Australia, BBC World, and The Hindu.
  • The World Health Organization classified talc as "probably carcinogenic to humans" in 2024, a claim carried by Al Jazeera.
  • J&J stopped selling talc-based baby powder in the US in 2020, as reported by ABC Australia and The Hindu, and worldwide in 2023, according to Al Jazeera.
  • Erik Haas, J&J's litigation head, said the agreement lets J&J "put this matter behind it," as quoted by ABC Australia, BBC World, and Al Jazeera.
  • A UK case alleges that J&J knew its talc could cause cancers, chiefly ovarian and mesothelioma, but continued to sell the product, as reported by Al Jazeera.

Perspectives

Johnson & Johnson: The company denies that its talc products caused cancer and maintains that talc is safe and does not contain asbestos. Erik Haas, vice president of litigation, called the claims "meritless" and expressed confidence that J&J would have prevailed in further litigation, but said the settlement allows the company to "put this matter behind it" and focus on its mission.

Plaintiffs' lawyers: Attorneys representing claimants welcomed the settlement as a good resolution after a decade-long court battle. Chris Seeger, an attorney representing about 2,500 clients with talc claims, said J&J could ultimately pay $7 billion or more, depending on participation.

UK claimants: A separate UK case, described as the largest product liability case in UK history, alleges that J&J knew its talc could cause cancers but continued to sell the product. This case is not covered by the US settlement.